Speaker Bio
Jiyoung Ahn, PhD
Professor, Department of Medicine at NYU Grossman School of Medicine
Dr. Jiyoung Ahn is a renowned cancer molecular epidemiologist specializing in the human microbiome and biomarkers for cancer development and progression. She currently leads three NCI R01-level projects as Principal Investigator and Project Director.
Dr. Ahn's groundbreaking research includes the novel discovery that the oral carriage of commensal beta-proteobacteria can predict the future development of head and neck cancers (JAMA Oncology, 2018) and esophageal cancer (Cancer Research, 2017). She has also demonstrated that several oral periodontal pathogenic bacteria are linked to an increased risk of pancreatic cancer (Gut, 2018). Dr. Ahn has served as a reviewer for multiple NIH and DOD study sections and international cancer research organizations in the UK, France, South Korea, and Japan. She recently co-chaired the organization of the American Association for Cancer Research (AACR) Meetings and is a senior editor of AACR's Cancer Epidemiology, Biomarkers, and Prevention. Her research excellence has been recognized with numerous awards and honors, including the NCI Outstanding Research Paper Award and the Woodrow Wilson Fellow Award.